The Palico Private Equity Fund Marketplace
Novo Seeds is a private equity general partner firm headquartered in Hellerup, Denmark.
Reapplix, a Denmark-based developer of device technology for tissue regeneration, raised €2.7m in funding from Novo Seeds and others.
Swiss biopharmaceutical company Inthera Bioscience has raised $3.7m in funding Aglaia BioMedical Ventures, Novo Seeds and others.
Clarus Ventures and Novo A/S have provided an undisclosed investment in Nuvelution Pharma.
Read more news concerning Novo Seeds
A sampling of Novo Seeds portfolio companies:
View all of the investments in their portfolio
This firm also pursues other investment strategies:
Registration is fast, free and easy
Already a member?